Latest Financial Results

Latest Annual Filing
For Fiscal Year Ending Dec 31, 2022
Report Links
Email Alerts
Sign up today and receive company updates straight to your inbox.
Company Overview
CohBar (NASDAQ: CWBR) is a clinical-stage biotechnology company leveraging the power of the mitochondria and the peptides encoded in its genome to develop potential breakthrough therapeutics targeting chronic and age-related diseases with limited to no treatment options. In November 2022, CohBar announced that it had initiated a process to explore and review a range of strategic alternatives.
IR Contacts
Headquarters
CohBar, Inc.
1455 Adams Drive
Suite 2050
Menlo Park, CA 94025
T: (650) 446-7888
info@cohbar.com
Investor Relations
Jordyn Tarazi
Director, Investor Relations
T: (650) 445-4441
jordyn.tarazi@cohbar.com
Transfer Agent
TSX Trust Company
301 – 100 Adelaide St W
Toronto, ON M5H 4H1